HRS/EHRA/APHRS/LAHRS/ACC/AHA Worldwide Practice Update for Telehealth and Arrhythmia Monitoring During and After a Pandemic

*Represen yRepresen zRepresen xRepresen {Represen #Represen Niraj Varma, MA, MD, PHD, FACC, FRCP, Chair Nassir F. Marrouche, MD, FHRS, Vice-Chair Luis Aguinaga, MD, MBA, PHD, FESC, FACC* Christine M. Albert, MD, MPH, FHRS, FACCd,y Elena Arbelo, MD, MSCI, PHDe,f,g,z Jong-Il Choi, MD, PHD, MHSh,x Mina K. Chung, MD, FHRS, FACCa,{ Giulio Conte, MD, PHDi,z Lilas Dagher, MDb,y Laurence M. Epstein, MD, FACCj,y Hamid Ghanbari, MD, FACCk,y Janet K. Han, MD, FHRS, FACCl,y Hein Heidbuchel, MD, PHD, FESC, FEHRAm,z He Huang, MD, FACC, FESC, FEHRAn,x Dhanunjaya R. Lakkireddy, MD, FHRS, FACCo,y

[1]  Jerrilyn Jones,et al.  Association of Treatment With Hydroxychloroquine or Azithromycin With In-Hospital Mortality in Patients With COVID-19 in New York State , 2020, The Journal of Emergency Medicine.

[2]  David R. Holtgrave,et al.  Association of Treatment With Hydroxychloroquine or Azithromycin With In-Hospital Mortality in Patients With COVID-19 in New York State , 2020, The Journal of Emergency Medicine.

[3]  G. Hripcsak,et al.  Observational Study of Hydroxychloroquine in Hospitalized Patients with Covid-19 , 2020, The New England journal of medicine.

[4]  Michael A. Spinelli,et al.  QT interval prolongation and torsade de pointes in patients with COVID-19 treated with hydroxychloroquine/azithromycin , 2020, Heart Rhythm.

[5]  L. Epstein,et al.  Effect of Chloroquine, Hydroxychloroquine, and Azithromycin on the Corrected QT Interval in Patients With SARS-CoV-2 Infection , 2020, Circulation. Arrhythmia and electrophysiology.

[6]  M. Ueda,et al.  Remote Management of Pacemaker Patients With Biennial In-Clinic Evaluation , 2020, Circulation. Arrhythmia and electrophysiology.

[7]  Nathaniel Hupert,et al.  Clinical Characteristics of Covid-19 in New York City , 2020, The New England journal of medicine.

[8]  D. Mann,et al.  COVID-19 Clinical Trials , 2020, JACC: Basic to Translational Science.

[9]  M. Eslami,et al.  Transient complete heart block in a patient with critical COVID-19 , 2020, European heart journal.

[10]  Erwan L'Her,et al.  Compassionate Use of Remdesivir for Patients with Severe Covid-19 , 2020, The New England journal of medicine.

[11]  C. Tondo,et al.  Cardiac and arrhythmic complications in patients with COVID‐19 , 2020, Journal of cardiovascular electrophysiology.

[12]  J. Healey,et al.  Guidance on Minimizing Risk of Drug-Induced Ventricular Arrhythmia During Treatment of COVID-19: A Statement from the Canadian Heart Rhythm Society , 2020, Canadian Journal of Cardiology.

[13]  P. Noseworthy,et al.  Urgent Guidance for Navigating and Circumventing the QTc-Prolonging and Torsadogenic Potential of Possible Pharmacotherapies for Coronavirus Disease 19 (COVID-19) , 2020, Mayo Clinic Proceedings.

[14]  L. Epstein,et al.  Inpatient use of mobile continuous telemetry for COVID-19 patients treated with hydroxychloroquine and azithromycin , 2020, HeartRhythm Case Reports.

[15]  Reyma Raju,et al.  How to protect the protectors: 10 lessons to learn for doctors fighting the COVID-19 coronavirus , 2020, Medical Journal Armed Forces India.

[16]  Zhan Zhang,et al.  Efficacy of hydroxychloroquine in patients with COVID-19: results of a randomized clinical trial , 2020, medRxiv.

[17]  Roberto Maroldi,et al.  Cardiac Involvement in a Patient With Coronavirus Disease 2019 (COVID-19). , 2020, JAMA cardiology.

[18]  Tao Guo,et al.  Cardiovascular Implications of Fatal Outcomes of Patients With Coronavirus Disease 2019 (COVID-19) , 2020, JAMA cardiology.

[19]  X. Bian,et al.  [A pathological report of three COVID-19 cases by minimally invasive autopsies]. , 2020, Zhonghua bing li xue za zhi = Chinese journal of pathology.

[20]  J. Hollander,et al.  Virtually Perfect? Telemedicine for Covid-19. , 2020, The New England journal of medicine.

[21]  K. Kim,et al.  What Is COVID-19? , 2020, Frontiers for Young Minds.

[22]  Shao-hua Hu,et al.  Online mental health services in China during the COVID-19 outbreak , 2020, The Lancet Psychiatry.

[23]  Yan Zhao,et al.  Clinical Characteristics of 138 Hospitalized Patients With 2019 Novel Coronavirus-Infected Pneumonia in Wuhan, China. , 2020, JAMA.

[24]  T. Bunch,et al.  HRS White Paper on interoperability of data from cardiovascular implantable electronic devices (CIEDs). , 2019, Heart Rhythm.

[25]  P. Sager,et al.  Assessment of Multi‐Ion Channel Block in a Phase I Randomized Study Design: Results of the CiPA Phase I ECG Biomarker Validation Study , 2019, Clinical pharmacology and therapeutics.

[26]  N. White,et al.  The arrhythmogenic cardiotoxicity of the quinoline and structurally related antimalarial drugs: a systematic review , 2018, BMC Medicine.

[27]  D. Yoon,et al.  Risk Evaluation of Azithromycin-Induced QT Prolongation in Real-World Practice , 2018, BioMed research international.

[28]  Aarti S. Dalal,et al.  Can smartphone wireless ECGs be used to accurately assess ECG intervals in pediatrics? A comparison of mobile health monitoring to standard 12-lead ECG , 2018, PloS one.

[29]  L. Epstein,et al.  Factors Influencing the Decision to Proceed to Firmware Upgrades to Implanted Pacemakers for Cybersecurity Risk Mitigation. , 2018, Circulation.

[30]  Peter J. Schwartz,et al.  A wearable remote monitoring system for the identification of subjects with a prolonged QT interval or at risk for drug-induced long QT syndrome. , 2018, International journal of cardiology.

[31]  G. Tomlinson,et al.  Electrocardiogram abnormalities related to anti-malarials in systemic lupus erythematosus. , 2018, Clinical and experimental rheumatology.

[32]  Wojciech Zareba,et al.  2017 ISHNE-HRS expert consensus statement on ambulatory ECG and external cardiac monitoring/telemetry. , 2017, Heart rhythm.

[33]  G. Hindricks,et al.  Daily remote monitoring of implantable cardioverter-defibrillators: insights from the pooled patient-level data from three randomized controlled trials (IN-TIME, ECOST, TRUST) , 2017, European heart journal.

[34]  Long Chen,et al.  Electrophysiologic Studies on the Risks and Potential Mechanism Underlying the Proarrhythmic Nature of Azithromycin , 2017, Cardiovascular Toxicology.

[35]  B. Lindsay,et al.  Association Between Off-site Central Monitoring Using Standardized Cardiac Telemetry and Clinical Outcomes Among Non-Critically Ill Patients. , 2016, JAMA.

[36]  Dwight Reynolds,et al.  Comparison of QT Interval Readings in Normal Sinus Rhythm Between a Smartphone Heart Monitor and a 12‐Lead ECG for Healthy Volunteers and Inpatients Receiving Sotalol or Dofetilide , 2016, Journal of cardiovascular electrophysiology.

[37]  Haipeng Xiao,et al.  The Role of Macrolide Antibiotics in Increasing Cardiovascular Risk. , 2015, Journal of the American College of Cardiology.

[38]  R. Ohannessian,et al.  Telemedicine: Potential applications in epidemic situations , 2015, European Research in Telemedicine / La Recherche Européenne en Télémédecine.

[39]  Renato Pietro Ricci,et al.  HRS Expert Consensus Statement on remote interrogation and monitoring for cardiovascular implantable electronic devices. , 2015, Heart rhythm.

[40]  J. Sin,et al.  Azithromycin and the Risk of Cardiovascular Complications , 2014, Journal of pharmacy practice.

[41]  H. Heidbuchel,et al.  EuroEco (European Health Economic Trial on Home Monitoring in ICD Patients): a provider perspective in five European countries on costs and net financial impact of follow-up with or without remote monitoring , 2014, European heart journal.

[42]  M. Peller,et al.  Kardia Mobile applicability in clinical practice: A comparison of Kardia Mobile and standard 12-lead electrocardiogram records in 100 consecutive patients of a tertiary cardiovascular care center , 2013, Cardiology journal.

[43]  B. Stambler,et al.  Same-day discovery of implantable cardioverter defibrillator dysfunction in the TRUST remote monitoring trial: influence of contrasting messaging systems , 2012, Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology.

[44]  Renato Pietro Ricci,et al.  Telemedicine and cardiac implants: what is the benefit? , 2012, European heart journal.

[45]  C Michael Stein,et al.  Azithromycin and the risk of cardiovascular death. , 2012, The New England journal of medicine.

[46]  B. Kuhn,et al.  Thorough QT/QTc study of tocilizumab after single-dose administration at therapeutic and supratherapeutic doses in healthy subjects. , 2011, International journal of clinical pharmacology and therapeutics.

[47]  R. Schweikert,et al.  Efficacy and Safety of Automatic Remote Monitoring for Implantable Cardioverter-Defibrillator Follow-Up: The Lumos-T Safely Reduces Routine Office Device Follow-Up (TRUST) Trial , 2010, Circulation.

[48]  U. Moretti,et al.  Antimicrobials and the Risk of Torsades de Pointes , 2010, Drug safety.

[49]  A. Dreisbach,et al.  Randomized Dose-Ranging Controlled Trial of AQ-13, a Candidate Antimalarial, and Chloroquine in Healthy Volunteers , 2007, PLoS clinical trials.

[50]  I. Cygankiewicz,et al.  The Cardiac Safety of Chloroquine Phosphate Treatment in Patients with Systemic Lupus Erythematosus: The Influence on Arrhythmia, Heart Rate Variability and Repolarization Parameters , 2006, Lupus.

[51]  Sanjit Bagchi,et al.  Telemedicine in Rural India , 2006, PLoS medicine.

[52]  R. Costa,et al.  Cardiac damage from chronic use of chloroquine: a case report and review of the literature. , 2002, Arquivos brasileiros de cardiologia.

[53]  R. F. I. Smith,et al.  Governance , 2001, The Corporation as a Protagonist in Global History, c. 1550-1750.

[54]  L. Rimmer,et al.  Comparison of 2 methods of measuring the QT interval. , 1998, American journal of critical care : an official publication, American Association of Critical-Care Nurses.

[55]  L. Rimmer Bedside monitoring of the QT interval. , 1998, American journal of critical care : an official publication, American Association of Critical-Care Nurses.

[56]  Richard L. Verrier,et al.  ISHNE-HRS expert consensus statement on ambulatory ECG and external cardiacmonitoring / telemetry , 2017 .

[57]  Janet Richards,et al.  Information governance. , 2006, Nursing standard (Royal College of Nursing (Great Britain) : 1987).

[58]  K. Jenpanich,et al.  [Drug administration]. , 1976, Thai journal of nursing.